(Q44229810)

1 December 2017

[18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour model (English)

1 reference

1 December 2017

0 references

1 reference

5

Guy Bormans

1 reference

1 December 2017

Ludwig Dubois

1

1 reference

1 December 2017

Willy Landuyt

2

1 reference

1 December 2017

Lieselotte Cloetens

3

1 reference

1 December 2017

Anne Bol

4

1 reference

1 December 2017

Karin Haustermans

6

1 reference

1 December 2017

Daniel Labar

7

1 reference

1 December 2017

Johan Nuyts

8

1 reference

1 December 2017

Vincent Grégoire

9

1 reference

1 December 2017

Luc Mortelmans

10

1 reference

1 December 2017

9 August 2008

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

1 December 2017

1 reference

1 December 2017

36

1 reference

1 December 2017

2

1 reference

1 December 2017

209-218

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-008-0907-x

1 December 2017

0 references

cites work

Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0907-X

Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0907-X

Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)- N-(3,3,3-[(18)F]trifluoropropyl)acetamide, [(18)F]EF3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0907-X

Experimental radiotherapy of a rat rhabdomyosarcoma with 15 MeV neutrons and 300 kV x-rays. I. Effects of single exposures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0907-X

Noninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0907-X

[(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0907-X

The detection and measurement of hypoxic cells in solid tumors

21 January 2018

1 reference

12 December 2020

Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.

1 reference

12 December 2020

Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

1 reference

12 December 2020

Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake.

1 reference

12 December 2020

Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia.

1 reference

12 December 2020

Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells

1 reference

12 December 2020

Quantifying tumour hypoxia with fluorine-18 fluoroerythronitroimidazole ([18F]FETNIM) and PET using the tumour to plasma ratio

1 reference

12 December 2020

Assessment of hypoxia in experimental mice tumours by [18F]fluoromisonidazole PET and pO2 electrode measurements. Influence of tumour volume and carbogen breathing

1 reference

12 December 2020

Hypoxia in the androgen-dependent Shionogi model for prostate cancer at three stages.

1 reference

12 December 2020

Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer

1 reference

12 December 2020

An efficient radiosynthesis of [18F]fluoromisonidazole

1 reference

12 December 2020

Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning.

1 reference

12 December 2020

[18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study

1 reference

12 December 2020

Influence of the hypoxic subvolume on the survival of patients with head and neck cancer

1 reference

12 December 2020

FDG--a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2-polarography in metastatic head and neck cancer

1 reference

12 December 2020

Patterns of tumor oxygenation and their influence on the cellular hypoxic response and hypoxia-directed therapies

1 reference

12 December 2020

Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.

1 reference

12 December 2020

Noninvasive detection of tumor hypoxia using the 2-nitroimidazole [18F]EF1.

1 reference

12 December 2020

Concepts of oxygen transport at the microcirculatory level.

1 reference

12 December 2020

Modulation of cell death in the tumor microenvironment

1 reference

12 December 2020

Imaging hypoxia in tumors

1 reference

12 December 2020

Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography--a study evaluating [18F]Fluoro-2-deoxy-D-glucose

1 reference

12 December 2020

18FFluoroazomycinarabinofuranoside (18FAZA) and 18FFluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors

1 reference

12 December 2020

Nitroimidazoles and imaging hypoxia

1 reference

12 December 2020

Determination of tumour hypoxia with the PET tracer [18F]EF3: improvement of the tumour-to-background ratio in a mouse tumour model.

1 reference

12 December 2020

Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer

1 reference

12 December 2020

Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide ].

1 reference

12 December 2020

Measurement of absolute oxygen levels in cells and tissues using oxygen sensors and 2-nitroimidazole EF5.

1 reference

12 December 2020

Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma

1 reference

12 December 2020

Imaging and quantitation of the hypoxic cell fraction of viable tumor in an animal model of intracerebral high grade glioma using [18F]fluoromisonidazole (FMISO).

1 reference

12 December 2020

Evaluation of hypoxia in an experimental rat tumour model by [(18)F]fluoromisonidazole PET and immunohistochemistry

1 reference

12 December 2020

Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients.

1 reference

12 December 2020

Detection of tumour hypoxia: comparison between EF5 adducts and [18F]EF3 uptake on an individual mouse tumour basis

1 reference

12 December 2020

Synthesis of [18F]-labeled EF3 [2-(2-nitroimidazol-1-yl)-N-(3,3,3-trifluoropropyl)-acetamide], a marker for PET detection of hypoxia

1 reference

12 December 2020

10.1007/S00259-008-0907-X

Identifiers

DOI

1 reference

1 December 2017

1 reference